Published Date: July 22, 2026
Incorporate anemia screenings for children and infants, and use the proper code for the appropriate Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) visit.
The American Academy of Pediatrics (AAP) and the American Family Physician (AFP) identify anemia screening as a universal screening. Despite this recognition, iron deficiency and iron-deficiency anemia continue to be of concern and can have adverse effects on neurodevelopment in infants and children.
Highmark Wholecare Providers should conduct anemia screenings at the following ages:
For more information, please refer to CDC Morbidity and Mortality Weekly Report (MMWR).
All EPSDT screening services must be reported with age-appropriate evaluation and management code along with the EP modifier:
Provider should choose the most appropriate test:
Modifier:
For questions regarding the EPSDT program, please contact HWC_EPSDTInfo@Highmark.com.
These codes are not all encompassing and use does not guarantee payment. They are intended as a guide to provide education around appropriate screenings and coding as part of the EPSDT program.